Get started
Author

Ayako Muramatsu

Observed names: Muramatsu Ayako, 彩子 村松, 村松, 彩子
ORCID: 0000-0003-4019-7218
Observed ORCID: 0000-0003-4019-7218
OpenAlex ID: A5082005924
Tumour‐derived exosomes promote the induction of monocytic myeloid‐derived suppressor cells from peripheral blood mononuclear cells by delivering miR ‐106a‐5p and miR ‐146a‐5p in multiple myeloma
2023 · Kentaro Mizuhara, Yuji Shimura, et al. · British Journal of Haematology · 25
Prediction of delayed platelet engraftment after autologous stem cell transplantation for B-cell non-Hodgkin lymphoma
2019 · Junko Yamaguchi, Yoshiaki Chinen, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 10
Diffuse large B cell lymphoma with chromosomal translocation t(14;19)(q32;q13) occurring in IgG4-related disease
2019 · Yuka Kawaji, Hiroaki Nagata, et al. · Annals of Hematology · 10
Prognostic impact of resistance to bortezomib and/or lenalidomide in carfilzomib‐based therapies for relapsed/refractory multiple myeloma: The Kyoto Clinical Hematology Study Group, multicenter, pilot, prospective, observational study in Asian patients
2021 · Yuka Kawaji‐Kanayama, Tsutomu Kobayashi, et al. · Cancer Reports · 9
Combination of Bone Marrow Biopsy and Flow Cytometric Analysis: The Prognostically Relevant Central Approach for Detecting Bone Marrow Invasion in Diffuse Large B-Cell Lymphoma
2021 · Haruya Okamoto, Nobuhiko Uoshima, et al. · Diagnostics · 8
PDF
Triple targeting of RSK, AKT, and S6K as pivotal downstream effectors of PDPK1 by TAS0612 in B‐cell lymphomas
2023 · Yoko Katsuragawa‐Taminishi, Shinsuke Mizutani, et al. · Cancer Science · 6
Successful management of acquired hemophilia A onset during pregnancy: A case report
2021 · Akane Nishi, Ayako Muramatsu, et al. · Journal of obstetrics and gynaecology research · 6
Gastric lymphoma complicated by phlegmonous gastritis and Guillain–Barré syndrome: A case report
2020 · Kodai Kuriyama, Yuki Koyama, et al. · Medicine · 6
Robust anti-myeloma effect of TAS0612, an RSK/AKT/S6K inhibitor, with venetoclax regardless of cytogenetic abnormalities
2024 · Haruya Okamoto, Shinsuke Mizutani, et al. · Leukemia · 5
Clinical impacts of frailty, poor performance status, and advanced age in carfilzomib-containing treatment for relapsed/refractory multiple myeloma: post hoc investigation of the KOTOSG multicenter pilot prospective observational study
2022 · Yuka Kawaji-Kanayama, Ayako Muramatsu, et al. · International Journal of Hematology · 5
Karyotype evolution of myelodysplastic syndrome and acute myeloid leukemia with TP53 mutations
2025 · Yosuke Matsumoto, Daishi Kato, et al. · International Journal of Hematology · 4
Recurrent intragenic exon rearrangements of SOBP and AUTS2 in non-Hodgkin B-cell lymphoma
2019 · Yosuke Matsumoto, Yoshiaki Chinen, et al. · International Journal of Hematology · 4
Incidence of hematologic cancer types in Japan by ICD-O-3 code: analysis of National Cancer Registry
2024 · Ayako Muramatsu, Tetsuji Kawakami · Future Science OA · 2
[Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis subsequent to rabbit antithymocyte globulin administration and successfully treated with rituximab in a patient with aplastic anemia].
2018 · Hiroaki Nagata, Takahiro Fujino, et al. · PubMed · 2
TAS0612, a Triple Inhibitor for RSK, AKT, and S6K, Is a Promising Anti-Myeloma Agent Regardless of Types of Cytogenetic/Genetic Abnormality
2023 · Haruya Okamoto, Shinsuke Mizutani, et al. · Blood · 1
PDF
Progressive Multifocal Leukoencephalopathy Initially Suspected As Brain Relapse From Classical Hodgkin’s Lymphoma
2023 · Akio Onishi, Ayako Muramatsu, et al. · Cureus · 1
PDF
Mir-106a-5p and Mir-146a-5p Delivered By Tumor-Derived Exosomes Promote the Induction of Myeloid-Derived Suppressor Cells from Normal Peripheral Blood Mononuclear Cells in Multiple Myeloma
2022 · Kentaro Mizuhara, Yuji Shimura, et al. · Blood · 1
Clinical Implication of the Effect of the Production of Neutralizing Antibodies Against SARS-Cov-2 for Chronic Immune Thrombocytopenia Flare-Up Associated with COVID-19 Infection: A Case Report and the Review of Literature
2022 · Chika Maekura, Ayako Muramatsu, et al. · Infection and Drug Resistance · 1
PDF
Pretreatment serum level of interleukin-6 predicts carfilzomib-induced hypertension in relapsed/refractory multiple myeloma
2022 · Ayako Muramatsu, Tsutomu Kobayashi, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 1
In Elderly Patients with Newly Diagnosed Aggressive B-Cell Lymphoma, the Rate of Change in Body Weight after the First Course R-CHOP (-like) Chemo Therapy Has Effect on Their Survival
2018 · Muramatsu Ayako, Nagata Hiroaki, et al. · Blood · 1
Karyotype evolution of multiple myeloma
2026 · Yosuke Matsumoto, Tsuyoshi Ichimura, et al. · Journal of the Japan Society of the Reticuloendothelial System
PDF
Trends and Outcomes of Hematopoietic Stem Cell Transplantation for Malignant Lymphoma in Japan between 2006 and 2021
2024 · Ayako Muramatsu, Ayumi Fujimoto, et al. · Blood
PDF
The Anti-Myeloma Efficacy of TAS0612, a Triple Inhibitor of RSK, AKT, and S6K, and Itssynergistic Combination with Venetoclax in Multiple Myeloma Irrespective of Cytogeneticabnormalities
2024 · Haruya Okamoto, Shinsuke Mizutani, et al. · Blood
Pretreatment serum level of interleukin-6 predicts carfilzomib-induced hypertension in relapsed/refractory multiple myeloma.
2024 · 村松, 彩子 · Institutional Repositories DataBase (IRDB)
The Activation Status of RSK2, but Not PDPK1 and AKT, Associates with the Prognosis of Diffuse Large B Cell Lymphoma
2023 · Akio Onishi, Aya Miyagawa-Hayashino, et al. · Blood
Works count: 34
Citation count: 108
H-index: 6
I10-index: 3
Year
Topic
Type